US Patent Issued to IOLYX THERAPEUTICS on Oct. 20 for "High concentration pharmaceutical compositions of roflumilast for ophthalmic delivery" (California Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,096, issued on Oct. 20, was assigned to IOLYX THERAPEUTICS INC. (Burlingame, Calif.).

"High concentration pharmaceutical compositions of roflumilast for ophthalmic delivery" was invented by Richard Graham (Irvine, Calif.), Elizabeth W. Jeffords (Hillsborough, Calif.), Hovhannes J. Gukasyan (Orange, Calif.) and Shannon Dahl (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to high concentration ophthalmic pharmaceutical formulations of the phosphodiesterase-4 inhibitor, roflumilast, which are suitable for intravitreal or other ocular administration to injection sites internal or external to the eye and or...